ResearcherSyntrix Biosystems, Inc.Active in the last 2 years

John A Zebala

Verified by NIH RePORTER profile ID (good confidence)As of 10 November 2026

Matched on NIH RePORTER profile ID 6765106.

Their work

Papers: 0
Trials: 0
Grants: 2
Collaborators: 1

Papers, trials and grants by year

2026: 2 grants

Grants 2

A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer… R44CA278187 ↗
A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients R44CA291622 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Aaron D Schuler · 2 shared grants, 2026
- Grant A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metasta… R44CA278187 ↗
- Grant A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients R44CA291622 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.